Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma

被引:0
作者
Lauwers, GY
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Gastrointestinal Pathol Serv, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
stomach; gastric cancer; adenocarcinoma; gastritis; Helicobacter pylori; atrophy; metaplasia; dysplasia;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Epidemiologic and pathologic studies have confirmed that the development of gastric cancer spans over several decades starting with Helicobacter pylori chronic active gastritis followed, over time and only in a subset of patients, with the development of intestinal metaplasia and atrophy, dysplasia, and finally gastric adenocarcinoma. It has also been established that the pathogenesis of gastric cancer is a multifactorial process in which both environmental and host-related factors play significant role. Improvement in upper endoscopic techniques make possible the detection of not only early gastric cancers but also the mucosal alterations that predate malignant degeneration. A better understanding of the gastric carcinogenic sequence will allow us to better identify the patients at risk and to implement preventive strategies. We review the histopathologic steps that predate the development of gastric cancer and evaluate the risks of transformation that they confer.
引用
收藏
页码:S37 / S43
页数:7
相关论文
共 101 条
  • [11] THE PROGNOSTIC VALUE OF SULFOMUCIN POSITIVE INTESTINAL METAPLASIA IN THE DEVELOPMENT OF GASTRIC-CANCER
    ECTORS, N
    DIXON, MF
    [J]. HISTOPATHOLOGY, 1986, 10 (12) : 1271 - 1277
  • [12] The importance of interleukin 1β in Helicobacter pylori associated disease
    El-Omar, EM
    [J]. GUT, 2001, 48 (06) : 743 - 747
  • [13] Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia:: Role of the Sydney system
    El-Zimaity, HMT
    Graham, DY
    [J]. HUMAN PATHOLOGY, 1999, 30 (01) : 72 - 77
  • [14] Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis
    ElZimaity, HMT
    Graham, DY
    AlAssi, MT
    Malaty, H
    Karttunen, TJ
    Graham, DP
    Huberman, RM
    Genta, RM
    [J]. HUMAN PATHOLOGY, 1996, 27 (01) : 35 - 41
  • [15] Early gastric cancer in Europe
    Everett, SM
    Axon, AT
    [J]. GUT, 1997, 41 (02) : 142 - 150
  • [16] EARLY AND ADVANCED GASTRIC-CANCER IN THE FOLLOW-UP OF MODERATE AND SEVERE GASTRIC DYSPLASIA PATIENTS - A PROSPECTIVE-STUDY
    FARINATI, F
    RUGGE, M
    DIMARIO, F
    VALIANTE, F
    BAFFA, R
    [J]. ENDOSCOPY, 1993, 25 (04) : 261 - 264
  • [17] FARLEY DR, 1992, SURG CLIN N AM, V72, P401
  • [18] CLINICAL-SIGNIFICANCE OF GASTRIC DYSPLASIA - A MULTICENTER FOLLOW-UP-STUDY
    FERTITTA, AM
    COMIN, U
    TERRUZZI, V
    MINOLI, G
    ZAMBELLI, A
    CANNATELLI, G
    BODINI, P
    BERTOLI, G
    NEGRI, R
    BRUNATI, S
    FIOCCA, R
    TURPINI, F
    PRADA, A
    CERETTI, E
    GULLOTTA, R
    CORNAGGIA, M
    [J]. ENDOSCOPY, 1993, 25 (04) : 265 - 268
  • [19] Filipe M. I., 1992, PROGR SURG PATHOLOGY, P269
  • [20] INCOMPLETE SULFOMUCIN-SECRETING INTESTINAL METAPLASIA FOR GASTRIC-CANCER - PRELIMINARY DATA FROM A PROSPECTIVE-STUDY FROM 3 CENTERS
    FILIPE, MI
    POTET, F
    BOGOMOLETZ, WV
    DAWSON, PA
    FABIANI, B
    CHAUVEINC, P
    FENZY, A
    GAZZARD, B
    GOLDFAIN, D
    ZEEGEN, R
    [J]. GUT, 1985, 26 (12) : 1319 - 1326